One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment

TAI-CHUNG TSENGChoi J.Nguyen M.H.Peng C.-Y.Siakavellas S.Papatheodoridis G.Wang C.-C.Lim Y.-S.Lai H.-C.Trinh H.N.Wong C.Wong C.Zhang J.Li J.JIA-HORNG KAO2021-09-042021-09-0420211936-0533https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100523620&doi=10.1007%2fs12072-020-10124-z&partnerID=40&md5=85eace1c354e65a5a8d0a7d93711ad3ehttps://scholars.lib.ntu.edu.tw/handle/123456789/581711[SDGs]SDG3One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatmentjournal article10.1007/s12072-020-10124-z335475572-s2.0-85100523620